Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Statistics
  • Help & Advice
University of Warwick

The Library

  • Login

Characteristics of low molecular weight heparin production by an ultrafiltration membrane bioreactor using maltose binding protein fused heparinase I

Tools
- Tools
+ Tools

Ye, Fengchun, Kuang, Ying, Chen, Shuo, Zhang, Chong, Chen, Yin and Xing, Xin-Hui. (2009) Characteristics of low molecular weight heparin production by an ultrafiltration membrane bioreactor using maltose binding protein fused heparinase I. Biochemical Engineering Journal, Vol.46 (No.2). pp. 193-198. ISSN 1369-703X

Full text not available from this repository.
Official URL: http://dx.doi.org/10.1016/j.bej.2009.05.007

Abstract

Low molecular weight heparin (LMWH) produced by the degradation of heparin has been widely used for clinical use, because it retains heparin's anticoagulant activity while has fewer side effects. In this study, a bioprocess for efficient production of LMWH was established by all ultrafiltration (UF) membrane bioreactor using maltose-binding protein (MBP)-heparinase I. The absorption of the reaction mixture at 235 nm (A(235)) was used as an indicator for monitoring the enzymatic reaction and product quality. When A(235) of the reaction mixture reached 45, the produced LMWH reached a weight-average molecular weight (M(w)) of approximately 5038 Da, a number-average molecular weight (M(n)) of 3498 Da, the anti-factor Xa activity of 154.95 +/- 5.80 IU/mg, and the ratio of anti-factor Xa activity to anti-factor IIa activity of 2.2, which all meet the standard of European Pharmacopoeia 5.0. The average molecular weight of LMWH showed a good linear relationship with the increment in A(235). These results indicated that the qualified LMWH could be produced by the UF membrane bioreactor using the fusion enzyme. (C) 2009 Elsevier B.V. All rights reserved.

Item Type: Journal Article
Subjects: Q Science > Q Science (General)
Divisions: Faculty of Science > Life Sciences (2010- )
Journal or Publication Title: Biochemical Engineering Journal
Publisher: Elsevier Science BV
ISSN: 1369-703X
Date: 2009
Volume: Vol.46
Number: No.2
Number of Pages: 6
Page Range: pp. 193-198
Identification Number: 10.1016/j.bej.2009.05.007
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access
Funder: Grant of NSF Key Projects of China
Grant number: 20336010, 20836004
URI: http://wrap.warwick.ac.uk/id/eprint/42458

Data sourced from Thomson Reuters' Web of Knowledge

Request changes to a record

Actions (login required)

View Item View Item
twitter

Email us: publications@warwick.ac.uk
Contact Details
About Us